Illuminating
the path
to patient
access.

Introducing Ella AI in Landscape iQ

Turn payer market shifts into answers with AI-powered insights
that reveal what changed—and why it matters.

MMIT: Mission Control

MMIT is the market access intelligence engine behind your team's decision-making—your Mission Control. We connect gold-standard coverage data, real-world payer behavior, AI-driven efficiency, and human expertise so you can navigate the unknown with confidence.

The State of Patient
Access 2026

AI-Powered Market Access

Turn trusted payer data into answers with Mosaic + Ella AI.

What’s Trending

On-Demand Webinar

Reducing Risk: 5 Steps
for a Fearless Launch

Pharma Company

IMPROVED ONCOLOGY BRAND UTILIZATION WITHIN 6 MONTHS

0 %

USE CASE

How IDN Formulary
Insights Drove a 17%
Utilization Gain

EBOOK

The Essentials of
Market Access: How to
Build a Strong
Commercialization
Strategy for Your Medical
Benefit Therapy

Infographic

Payer Enrollment Data

INFOGRAPHIC

Unmatched Payer
Market Clarity

Thought Leadership

From Prior Authorization
to Clinical Pathways:
The Growing Role of AI
in Payer Strategy

On-Demand Webinar

Uncovering New Rare
Disease Patients Using
Structured and Unstructured
Real-World Data

case study

Closing Market Access Gaps
With MMIT’s Core Solutions

VIDEO

See how MMIT is
Illuminating the path
to Patient Access

use-case

Smoothing Patient Access
in Rare Disease

VIDEO

The Power of
Real-World Data

thought leadership

How Copay
Accumulators and
Maximizers Affect
Pharma PAPs

use-case

NorstellaLinQ: Targeting
Patients and Fueling
Brand Strategy with
Trigger Alerts

State of Patient Access Report

%

Of pharma execs say the market access planning timeline has shifted earlier over the past 5 years.

NorstellaLinQ

billion

Number of data points harnessed via our fully integrated data asset.

Market Research

Number of active panelists on MMIT’s payer panel.

“Throughout my 10 years in market access, I’ve been exposed to most of the top solutions, at times simultaneously. I’ve always found myself turning to MMIT because of their products’ ease of use and data integrity.”

Payer Data Intelligence
Solutions

Payer and Provider Insights Solutions

Payer and Specialty Pharmacy Solutions

Promotional Solutions

Market Access

Brand Performance and Strategy

Contracting and Reimbursement

Illuminating
the path
to patient
access.

Introducing Ella AI in Landscape iQ

MMIT: Mission Control

The State of Patient
Access 2026

AI-Powered Market Access

What’s Trending

Reducing Risk: 5 Steps
for a Fearless Launch

How IDN Formulary
Insights Drove a 17%
Utilization Gain

The Essentials of
Market Access: How to
Build a Strong
Commercialization
Strategy for Your Medical
Benefit Therapy

Payer Enrollment Data

Unmatched Payer
Market Clarity

From Prior Authorization
to Clinical Pathways:
The Growing Role of AI
in Payer Strategy

First Year After Launch:
Achieving Your
Uptake Goals

Market Access 101:
Understanding
the Basics

Mobilizing Data for
Product Launch Success

Promotional Strategies

Using Coverage Data to Achieve Brand Goals

Uncovering New Rare
Disease Patients Using
Structured and Unstructured
Real-World Data

Closing Market Access Gaps
With MMIT’s Core Solutions

See how MMIT is
Illuminating the path
to Patient Access

Smoothing Patient Access
in Rare Disease

The Power of
Real-World Data

How Copay
Accumulators and
Maximizers Affect
Pharma PAPs

NorstellaLinQ: Targeting
Patients and Fueling
Brand Strategy with
Trigger Alerts

State of Patient Access Report

%

NorstellaLinQ

billion

Market Research

Jai Persico,

National Account Executive,
Neurocrine Biosciences

CONTACT US

About us

Payer Data Intelligence Solutions

Payer and Provider Insights Solutions

Payer and Specialty Pharmacy Solutions

Promotional Solutions

Market Access

Brand Performance and Strategy

Contracting and Reimbursement

Illuminatingthe path to patientaccess.

Introducing Ella AI in Landscape iQ

MMIT: Mission Control

The State of Patient Access 2026

AI-Powered Market Access

What’s Trending

Reducing Risk: 5 Steps for a Fearless Launch

How IDN Formulary Insights Drove a 17% Utilization Gain

The Essentials of Market Access: How to Build a Strong Commercialization Strategy for Your Medical Benefit Therapy

Payer Enrollment Data

Unmatched Payer Market Clarity

From Prior Authorization to Clinical Pathways: The Growing Role of AI in Payer Strategy

First Year After Launch: Achieving Your Uptake Goals

Market Access 101: Understanding the Basics

Mobilizing Data for Product Launch Success

Promotional Strategies

Using Coverage Data to Achieve Brand Goals

Uncovering New RareDisease Patients UsingStructured and UnstructuredReal-World Data

Closing Market Access GapsWith MMIT’s Core Solutions

See how MMIT isIlluminating the pathto Patient Access

Smoothing Patient Accessin Rare Disease

The Power ofReal-World Data

How CopayAccumulators andMaximizers AffectPharma PAPs

NorstellaLinQ: TargetingPatients and FuelingBrand Strategy withTrigger Alerts

State of Patient Access Report

%

NorstellaLinQ

billion

Market Research

Jai Persico,

National Account Executive,Neurocrine Biosciences

CONTACT US

The State of Patient Access 2026

Payer Data Intelligence
Solutions

Illuminating
the path
to patient
access.

The State of Patient
Access 2026

Reducing Risk: 5 Steps
for a Fearless Launch

How IDN Formulary
Insights Drove a 17%
Utilization Gain

The Essentials of
Market Access: How to
Build a Strong
Commercialization
Strategy for Your Medical
Benefit Therapy

Unmatched Payer
Market Clarity

From Prior Authorization
to Clinical Pathways:
The Growing Role of AI
in Payer Strategy

First Year After Launch:
Achieving Your
Uptake Goals

Market Access 101:
Understanding
the Basics

Mobilizing Data for
Product Launch Success

Uncovering New Rare
Disease Patients Using
Structured and Unstructured
Real-World Data

Closing Market Access Gaps
With MMIT’s Core Solutions

See how MMIT is
Illuminating the path
to Patient Access

Smoothing Patient Access
in Rare Disease

The Power of
Real-World Data

How Copay
Accumulators and
Maximizers Affect
Pharma PAPs

NorstellaLinQ: Targeting
Patients and Fueling
Brand Strategy with
Trigger Alerts

National Account Executive,
Neurocrine Biosciences